We have been unable to detect the reported A908G mutation of ER-α in genomic DNA from any case of invasive carcinoma in our study, despite applying a sensitive and robust assay capable of detecting mutant if present in as little as 1% of the starting DNA. Here, ESR1 is linked to invasive carcinoma.